FDA Approves Adamis Pharmaceuticals’ EpiPen Competitor
Amid a firestorm of controversy surrounding Mylan’s EpiPen, the FDA has approved an alternative.
Source: Drug Industry Daily
Amid a firestorm of controversy surrounding Mylan’s EpiPen, the FDA has approved an alternative.
Source: Drug Industry Daily